產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-C2orf68抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-C2orf68抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-C2orf68
Cat. Number:
Anti-C2orf68抗體KL-9810R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
C2orf68, also known as Anti-C2orf68抗體FLJ14112, FLJ35653 or MGC131675, is a 168 amino acid protein belonging to the UPF0561 family. Existing as two alternatively spliced isoforms, C2orf68 is encoded by a gene that maps to human chromosome 2q11.2. As the second largest human chromosome, chromosome 2 makes up approximately 8% of the human genome and contains 237 million bases encoding over 1,400 genes. A number of genetic diseases are linked to genes on chromosome 2. Harlequin icthyosis, a rare skin deformity, is associated with mutations in the ABCA12 gene. The lipid metabolic disorder sitosterolemia is associated with ABCG5 and ABCG8. An extremely rare recessive genetic disorder, Alstr鰉 syndrome, is related to mutations in the ALMS1 gene. Chromosome 2 contains a probable vestigial second centromere as well as vestigial telomeres, which gives credence to the hypothesis that human chromosome 2 formed as a result of an ancient fusion of two ancestral chromosomes, which are still present in modern day apes.
Also known as:
Chromosome 2 openAnti-C2orf68抗體 reading frame 68; FLJ14112; FLJ35653; MGC131675; CB068_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C2orf68.
●
Predicted Molecular Anti-C2orf68抗體Weight: 19kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200 IEM=1:20-200 IGS=1:20-200 GICA=1:20-200
Not yet tested in other applications.
Optimal working Anti-C2orf68抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-C2orf68抗體dilutions must be determined by the end user.
kl593Ra02 肌原纖蛋白1(FBN1)多克隆抗體 Polyclonal Antibody to Fibrillin 1 (FBN1)
kl593Mu03 肌原纖蛋白1(FBN1)多克隆抗體 Polyclonal Antibody to Fibrillin 1 (FBN1)
kl593Mu02 肌原纖蛋白1(FBN1)多克隆抗體 Polyclonal Antibody to Fibrillin 1 (FBN1)
kl576Hu03 磷脂酶A2激活蛋白(PLAA)多克隆抗體 Polyclonal Antibody to Phospholikle A2 Activating Protein (PLAA)
kl575Hu02 胃動(dòng)素(MTL)多克隆抗體 Polyclonal Antibody to Motilin (MTL)
kl560Hu02 表皮生長(zhǎng)因子(EGF)多克隆抗體 Polyclonal Antibody to Epidermal Growth Factor (EGF)
kl517Hu02 角蛋白15(KRT15)多克隆抗體 Polyclonal Antibody to Keratin 15 (KRT15)
kl292Ra03 α-胞襯蛋白(SPTAN1)多克隆抗體 Polyclonal Antibody to Alpha-Fodrin (SPTAN1)
kl292Mu04 α-胞襯蛋白(SPTAN1)多克隆抗體 Polyclonal Antibody to Alpha-Fodrin (SPTAN1)
kl292Hu03 α-胞襯蛋白(SPTAN1)多克隆抗體 Polyclonal Antibody to Alpha-Fodrin (SPTAN1)
kl292Hu02 α-胞襯蛋白(SPTAN1)多克隆抗體 Polyclonal Antibody to Alpha-Fodrin (SPTAN1)
kl262Hu02 轉(zhuǎn)鐵蛋白受體2(TFR2)多克隆抗體 Polyclonal Antibody to Transferrin Receptor 2 (TFR2)
kl243Mu02 對(duì)氧磷酶1(PON1)多克隆抗體 Polyclonal Antibody to klaoxonase 1 (PON1)
kl235Mu03 補(bǔ)體1抑制因子(C1INH)多克隆抗體 Polyclonal Antibody to Complement 1 Inhibitor (C1INH)
kl235Mu02 補(bǔ)體1抑制因子(C1INH)多克隆抗體 Polyclonal Antibody to Complement 1 Inhibitor (C1INH)
kl221Mu04 轉(zhuǎn)錄因子20(TCF20)多克隆抗體 Polyclonal Antibody to Transcription factor 20 (TCF20)
kl221Mu03 轉(zhuǎn)錄因子20(TCF20)多克隆抗體 Polyclonal Antibody to Transcription factor 20 (TCF20)
kl220Ra02 腎上腺髓質(zhì)素(ADM)多克隆抗體 Polyclonal Antibody to Adrenomedullin (ADM)
kl207Hu02 谷丙轉(zhuǎn)氨酶(ALT)多克隆抗體 Polyclonal Antibody to Alanine Aminotransferase (ALT)
kl172Mu02 血小板因子4(PF4)多克隆抗體 Polyclonal Antibody to Platelet Factor 4 (PF4)
kl150Hu02 癌胚抗原(CEA)多克隆抗體 Polyclonal Antibody to Carcinoembryonic Antigen (CEA)
